A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
A monoclonal antibody (anti-B1) specific for a unique B cell surface differentiation antigen was used to characterize the malignant cells from patients with leukemias or lymphomas. All tumor cells from patients with lymphomas or chronic lymphocytic leukemias, bearing either monoclonal kappa lambda l...
में बचाया:
| में प्रकाशित: | J Clin Invest |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
American Society for Clinical Investigation
1981
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371580/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6969730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110005 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|